Health-related quality of life in a randomized phase III study of bevacizumab, temozolomide, and radiotherapy in newly diagnosed glioblastoma

Journal of Clinical Oncology

Volumn 33, Issue 19, 2015, Pages 2166-2175

  Taphoorn, Martin J B ^a   Henriksson, Roger ^b   Bottomley, Andrew ^c   Cloughesy, Timothy ^d   Wick, Wolfgang ^f   Mason, Warren P ^g   Saran, Frank ^h   Nishikawa, Ryo ⁱ   Hilton, Magalie ^j   Theodore Oklota, Christina ^e   Ravelo, Arliene ^e   Chinot, Olivier L ^k  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b UMEÅ UNIVERSITY   (Sweden)

^c EORTC DATA CENTER   (Belgium)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e GENENTECH INC   (United States)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g PRINCESS MARGARET HOSPITAL   (Canada)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁱ SAITAMA MEDICAL UNIVERSITY   (Japan)

^j F HOFFMANN LA ROCHE LTD   (Switzerland)

^k AIX MARSEILLE UNIVERSITY   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; PLACEBO; TEMOZOLOMIDE; ALKYLATING AGENT; ANGIOGENESIS INHIBITOR; DACARBAZINE; MONOCLONAL ANTIBODY;

ADD ON THERAPY; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DETERIORATION; DETERIORATION FREE SURVIVAL; DOUBLE BLIND PROCEDURE; FEMALE; GLIOBLASTOMA; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; ANALOGS AND DERIVATIVES; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; CLINICAL TRIAL; DISEASE COURSE; MIDDLE AGED; QUESTIONNAIRE; SURVIVAL; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; DACARBAZINE; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PLACEBOS; QUALITY OF LIFE; QUESTIONNAIRES; SURVIVAL ANALYSIS;

EID: 84937131897     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.60.3217     Document Type: Article

References (35)

1. Adamson C, Kanu OO, Mehta AI, et al: Glioblastoma multiforme: A review of where we have been and where we are going. Expert Opin Investig Drugs 18:1061-1083, 2009
2. Ohgaki H: Epidemiology of brain tumors. Methods Mol Biol 472:323-342, 2009
3. Henriksson R, Asklund T, Poulson HS: Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: A review. J Neurooncol 104:639-646, 2011
4. Osoba D, Aaronson NK, Muller M, et al: Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma. J Neurooncol 34:263-278, 1997
5. Taphoorn MJ, Klein M: Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3:159-168, 2004
6. Taphoorn MJ, Sizoo EM, Bottomley A: Review on quality of life issues in patients with primary brain tumors. Oncologist 15:618-626, 2010
7. Corn BW, Wang M, Fox S, et al: Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03. J Neurooncol 95:247-257, 2009
8. Chiu L, Chiu N, Zeng L, et al: Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30. Expert Rev Pharmacoecon Outcomes Res 12:831-837, 2012
9. Meyers CA, Rock EP, Fine HA: Refining endpoints in brain tumor clinical trials. J Neurooncol 108:227-230, 2012
10. Archibald YM, Lunn D, Ruttan LA, et al: Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg 80:247-253, 1994
11. Hottinger AF, Yoon H, DeAngelis LM, et al: Neurological outcome of long-term glioblastoma survivors. J Neurooncol 95:301-305, 2009
12. Regine WF, Huhn JL, Patchell RA, et al: Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: Results and implications. Int J Radiat Oncol Biol Phys 52:333-338, 2002
13. Patchell RA, Tibbs PA, Regine WF, et al: Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial. JAMA 280:1485-1489, 1998
14. Meyers CA, Smith JA, Bezjak A, et al: Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: Results of a randomized phase III trial. J Clin Oncol 22:157-165, 2004
15. Klein M, Heimans JJ, Aaronson NK, et al: Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: A comparative study. Lancet 360:1361-1368, 2002
16. Torres IJ, Mundt AJ, Sweeney PJ, et al: A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors. Neurology 60:1113-1118, 2003
17. Brown PD, Jensen AW, Felten SJ, et al: Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma. J Clin Oncol 24:5427-5433, 2006
18. Osoba D, Brada M, Yung WK, et al: Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide. Eur J Cancer 36:1788-1795, 2000
19. Genentech: Highlights of Prescribing Information [for Avastin (bevacizumab)]. http://www.gene.com/download/pdf/avastin-prescribing.pdf
20. Chugai Pharmaceutical: Anti-cancer agent "Avastin," obtained approval for additional indication and dosage and administration of malignant glioma. http://www.chugai-pharm.co.jp/hc/ss/english/news/detail/20130614150002.html
21. Chinot OL, Wick W, Mason W, et al: Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med 370:709-722, 2014
22. Gilbert MR, Dignam JJ, Armstrong TS, et al: A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370:699-708, 2014
23. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993
24. Bottomley A, Aaronson NK: International perspective on health-related quality-of-life research in cancer clinical trials: The European Organisation for Research and Treatment of Cancer experience. J Clin Oncol 25:5082-5086, 2007
25. Osoba D, Brada M, Prados MD, et al: Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro Oncol 2:221-228, 2000
26. Taphoorn MJ, Claassens L, Aaronson NK, et al: An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer 46:1033-1040, 2010
27. Fayers P, Aaronson N, Bjordal K, et al: EORTC QLQ-C30 Scoring Manual. Brussels, Belgium, EORTC Publications, 2001
28. Osoba D, Rodrigues G, Myles J, et al: Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16:139-144, 1998
29. Yung WK, Albright RE, Olson J, et al: A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83:588-593, 2000
30. Yavas C, Zorlu F, Ozyigit G, et al: Healthrelated quality of life in high-grade glioma patients: A prospective single-center study. Support Care Cancer 20:2315-2325, 2012
31. Taphoorn MJ, Stupp R, Coens C, et al: Health-related quality of life in patients with glioblastoma: A randomised controlled trial. Lancet Oncol 6:937-944, 2005
32. Armstrong T, Won M, Wefel JS, et al: Comparative impact of treatment on patient reported outcomes (PROs) in patients with glioblastoma (GBM) enrolled in RTOG 0825. J Clin Oncol 31:114s, 2013 (suppl; abstr 2003)
33. Chinot OL, Wick W, Cloughesy T: Bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370:2049, 2014
34. Walker M, Brown J, Brown K, et al: Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma. J Neurooncol 63:179-186, 2003
35. Keime-Guibert F, Chinot O, Taillandier L, et al: Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527-1535, 2007